Narrow your search
A breakthrough laser technology can discriminate between cancerous prostate cells and healthy bodily fluids, and ultimately help predict when cancer will metastasize.
Researchers in England say the culprit, called WWP2, is an enzymatic bonding agent in cancer cells that attacks the body's natural inhibitors of the spread of cancer.
New database and software, called ChEA, is designed to revolutionize how researchers identify drug targets and biomarkers, the developers at Mount Sinai report.
Researchers demonstrate for the first time that the previously reported metastasis-inducing protein can be detected in the blood of ovarian cancer patients.